Transparency data

Non-tech summaries 2016: projects on urogenital disorders

Projects granted during 2016 that have a primary purpose of translational research - human urogenital/reproductive disorders.

• From: Home Office
• Published: 21 December 2017

Documents

Non-technical summaries: projects granted in 2016, volume 24

PDF, 453 KB, 63 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2016 with a primary purpose of translational research - human urogenital/reproductive disorders.

The following projects were granted:

• the pathophysiology of endometriosis (endometrium, endometriosis, macrophage, nerves)

• mechanisms of uterine physiology and pathology (endometrium, bleeding, menstruation, fibroids)

• molecular factors affecting sperm production and function (fertility, reproduction, sperm, sex ratio)

• understanding and treating pregnancy related disorders (pregnancy, preterm labour, parturition, uterus, cervix)

• vitamin D and immune function (vitamin d, colon, pregnancy, placenta, inflammation)

• precursor cell therapies for kidney diseases (kidney cell mouse therapy scanning)

• improving organ function in kidney transplantation (renal, transplant, therapy, regenerative)

• rodent models of kidney disease (rodent models, kidney disease)

• the effects of aging on tissue injury and repair (kidney, acute injury, chronic fibrosis)

• endometrial function and associated disorders (uterus, steroid, inflammation, repair, endometriosis)

• optimising ovarian tissue transplantation by improving vascularisation (fertility preservation, xenografting, nude mouse, human ovarian tissue, transplantation)

• mechanism of bladder cancer and translation (Cre-LoxP, carcinogen, FGFR3, CXCR2, cell free DNA)

• optimisation of drug efficacy and safety in bladder cancer (cancer, chemotherapy, toxicity)

• pkcα and vascular calcification in kidney dysfunction (PKCα, vascular calcification, chronic kidney disease)

• decellularised biomaterials for homologous use in urinary bladder auto-augmentation (biomaterial, urinary tract, detrusorotomy, bladder)

• modelling therapies for renal malformations (kidney, ureter, bladder, malformation, therapy)

• the causes and treatment of rejection of kidney (alloimunity, inflammation, tissue scarring, kidney disease)

• biochemical pathways in renal fibrosis (renal, kidney, fibrosis, therapeutic)

• regenerative medicine therapy for renal injury (regenerative medicine, cell therapy, kidney, injury)

Published 21 December 2017